Search

Search bills, members, committees and pages...

H.R. 1108

U.S. HouseIn House Committee

Summary

H.R. 1108, the Diagnostics Testing Preparedness Plan Act of 2025, was introduced in the House on Feb 7, 2025 by Rep. Mariannette Miller-Meeks (R) with 3 co-sponsors. It was referred to Energy And Commerce, and last saw action on Feb 7, 2025: Referred to the House Committee on Energy and Commerce.


Record

Text

H.R. 1108 has 3 co-sponsors.

hb1108/introduced-in-house.txt
119 HR 1108 IH: Diagnostics Testing Preparedness Plan Act of 2025
U.S. House of Representatives
2025-02-07
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
I 119th CONGRESS 1st Session H. R. 1108 IN THE HOUSE OF REPRESENTATIVES February 7, 2025 Mrs. Miller-Meeks (for herself, Ms. Schrier , Mr. Crenshaw , and Mr. Carson ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL
To amend the Public Health Service Act to direct the Secretary of Health and Human Services to develop a plan to improve the development and distribution of diagnostic tests during a public health emergency, and for other purposes.
1.
Short title
This Act may be cited as the Diagnostics Testing Preparedness Plan Act of 2025 .
2.
Improving development and distribution of diagnostic tests
Section 319B of the Public Health Service Act ( 42 U.S.C. 247d–2 ) is amended to read as follows:
319B.
Improving development and distribution of diagnostic tests
(a)
Diagnostic testing preparedness plan
The Secretary shall develop, make publicly available, and update a plan for the rapid development, validation, authorization, manufacture, procurement, and distribution of diagnostic tests, and for rapid scaling of testing capacity, in response to chemical, biological, radiological, or nuclear threats, including emerging infectious diseases, for which a public health emergency is declared under section 319, or that has significant potential to cause such a public health emergency.
(b)
Purposes
The purpose of the plan under subsection (a) shall be to—
(1)
facilitate the development and utilization of diagnostic tests;
(2)
describe the processes for the rapid development, validation, authorization, manufacture, procurement, and distribution of diagnostic tests, and for rapid scaling of testing capacity; and
(3)
facilitate coordination and collaboration among public and private entities to improve the rapid development and utilization of diagnostic testing during a public health emergency.
(c)
Considerations
The plan under subsection (a) shall take into consideration—
(1)
domestic capacity, including any such capacity established through partnerships with public and private entities pursuant to subsection (e), to support the development, validation, manufacture, procurement, and distribution of tests, and the rapid scaling of testing capacity;
(2)
novel technologies and platforms that—
(A)
may be used to improve testing capabilities, including—
(i)
high-throughput laboratory diagnostics;
(ii)
point-of-care diagnostics; and
(iii)
rapid at-home diagnostics;
(B)
improve the accessibility of diagnostic tests; and
(C)
facilitate the development and manufacture of diagnostic tests;
(3)
medical supply needs related to testing, including diagnostic testing, equipment, supplies, and component parts, and any potential vulnerabilities related to the availability of such medical supplies and related planning needs, consistent with section 2811(b)(4)(J);
(4)
strategies for the rapid and efficient distribution of tests locally, regionally, or nationwide and appropriate scaling of laboratory testing capacity; and
(5)
assessment of such strategies through drills and operational exercises carried out under section 2811(b)(4)(G), as appropriate.
(d)
Coordination
To inform the development and update of the plan under subsection (a), and in carrying out activities to implement such plan, the Secretary shall coordinate with industry, such as device manufacturers, clinical and reference laboratories, and medical product distributors, States, local governmental entities, Indian Tribes and Tribal organizations, and other relevant public and private entities.
(e)
Capacity building
The Secretary may contract with public and private entities, as appropriate, to increase domestic capacity in the rapid development, validation, authorization, manufacture, procurement, and distribution of diagnostic tests, as appropriate, to State, local, and Tribal health departments and other appropriate entities for immediate public health response activities to address an infectious disease with respect to which a public health emergency is declared under section 319, or that has significant potential to cause such a public health emergency.
(f)
Deadlines for plan
(1)
Public release
Not later than one year after the date of enactment of the Diagnostics Testing Preparedness Plan Act of 2025 , the Secretary shall publicly release the plan developed under subsection (a).
(2)
Updates
The Secretary shall update such plan not less frequently than once every 3 years after the date of the initial public release of the plan.
.

Tracker

The tracker indicates the progress of this legislation as it moves through the legislative process.

  1. Introduced2025-02-07
  2. Passed House
  3. Passed Senate
  4. Conference
  5. To President
  6. Became Law

CRS Summary

The summaries are the Congressional Research Service’s, one per stage. Read them in full.

Introduced in House Feb 7, 2025

hb1108/introduced-in-house.md

Shown Here:
Introduced in House (02/07/2025)

Sponsors

Rep. Mariannette Miller-Meeks (R) sponsors H.R. 1108, and 3 members have co-sponsored it, all of them from the day it was introduced.

Committees

H.R. 1108 went before 1 committee: Energy and Commerce.

Energy and Commerce
Energy and Commerce
Referred To · Feb 7, 2025 · 1,636 Bills

Actions

H.R. 1108 has taken 2 actions since Feb 7, 2025.

ChamberAction
Feb 7, 2025
House
Introduced in House
Feb 7, 2025
House
Referred to the House Committee on Energy and Commerce.Energy and Commerce Committee

Votes

H.R. 1108 has not gone to a roll call.

2 bills are related to H.R. 1108.

Titles

H.R. 1108 goes by 3 titles, 1 of them short titles.

  • Diagnostics Testing Preparedness Plan Act of 2025 — Display Title
  • Diagnostics Testing Preparedness Plan Act of 2025 — Short Title(s) as Introduced
  • To amend the Public Health Service Act to direct the Secretary of Health and Human Services to develop a plan to improve the development and distribution of diagnostic tests during a public health emergency, and for other purposes. — Official Title as Introduced

Lobbying

1 client hired 1 firm and 4 registered lobbyists who named H.R. 1108 in 6 quarterly filings, 2025 to 2026. Reported under the Lobbying Disclosure Act; a filing’s income covers everything its registrant worked that quarter, so the amounts below are the filings’, not this bill’s.

Filed under Foreign Relations, Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid.

Clients

Who paid to be heard, by how many filings named the bill.

ClientBusinessStateFirmsFilingsReported
F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATESDistrict of Columbia16

Firms

Registrants who filed on the bill, by filings.

RegistrantClientsFilingsReported
F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES16

Lobbyists

Named on the filings that cite the bill.

LobbyistFirmsClientsFilings
BRENNA LEAMER116
CASSANDRA RICCI116
NANCY CARLTON116
RUSSELL RING116

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, largest reported first.

ClientRegistrantPeriodReportedDocument
F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATESF. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES2026 first_quarter$160K1st Quarter - Report
F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATESF. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES2025 first_quarter$130K1st Quarter - Report
F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATESF. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES2025 second_quarter$100K2nd Quarter - Report
F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATESF. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES2026 second_quarter$90K2nd Quarter - Report
F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATESF. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES2025 fourth_quarter$90K4th Quarter - Report
F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATESF. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES2025 third_quarter$90K3rd Quarter - Report

Classification

The Congressional Research Service files H.R. 1108 under Health, one of its 31 policy areas, and gives it 7 legislative subjects.

CRS Subjects

CRS assigns every bill one policy area from its 31; H.R. 1108’s is Health.

hr1108/policy-areas.txt
HealthAgriculture and FoodAnimalsArmed Forces and National SecurityArts, Culture, ReligionCivil Rights and Liberties, Minority IssuesCommerceCongressCrime and Law EnforcementEconomics and Public FinanceEducationEmergency ManagementEnergyEnvironmental ProtectionFamiliesFinance and Financial SectorForeign Trade and International FinanceGovernment Operations and PoliticsHousing and Community DevelopmentImmigrationInternational AffairsLabor and EmploymentLawNative AmericansPublic Lands and Natural ResourcesScience, Technology, CommunicationsSocial WelfareSports and RecreationTaxationTransportation and Public WorksWater Resources Development

Legislative Subjects

H.R. 1108 carries 7 of CRS’s legislative subjects, from Emergency planning and evacuation to Research and development.

hr1108/subjects.txt
Emergency planning and evacuationInfectious and parasitic diseasesIntergovernmental relationsManufacturingMedical tests and diagnostic methodsPublic contracts and procurementResearch and development

Source: congress.gov · legiscan.com